Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
Members of the Prostate Cancer Roundtable have received a letter from the Agency for Healthcare Research and Quality (AHRQ) addressing issues raised by the Roundtable members about the draft USPSTF recommendations on use of the PSA test in screening for risk of prostate cancer.
Filed under: Diagnosis, Risk | Tagged: PSA, risk, screening, testing | 2 Comments »
According to an announcement on the web site of Congressmen Dennis Kucinich late yesterday, HHS Secretary Kathleen Sebelius has agreed to overule the draft recommendation issued by the U.S. Preventive Services Task Force (USPSTF) related to the use of PSA testing as a means to detect prostate cancer.
Filed under: Diagnosis, Risk | Tagged: Diagnosis, PSA, rfisk, screening, testing | 9 Comments »
A new article published on line late Friday in the Journal of the National Cancer Institute shows “no evidence of a mortality benefit for organized annual screening in the PLCO trial compared with opportunistic screening” for prostate cancer.
Filed under: Diagnosis, Risk | Tagged: mortality, risk, screening, testing | 11 Comments »
Now here’s a new perspective on the value of widespread prostate cancer screening from one of the founders of Prostate Cancer Awareness Week — Dr. David Crawford of the University of Colorado Health Science Center in Denver, CO (who is also the Chairman of the Prostate Conditions Education Council):
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: elderly, screening, testing, value | 2 Comments »
The value of regular testing of increasingly elderly men and women for risk of cancer is controversial. However, a new paper in the Archives of Internal Medicine has certainly added to our knowledge of just how widespread such testing may be … at least in the USA.
Filed under: Diagnosis, Management, Risk | Tagged: elderly, recommendation, screening, testing | 8 Comments »
The October issue of the Canadian Journal of Urology contains an interesting and thorough review of the available data on the value of screening for prostate cancer as seen by a group including urologists, urologic oncologists, medical oncologists, radiation oncologists, and a highly regarded primary care physician.
Filed under: Diagnosis, Risk | Tagged: mortality, PSA, risk, screening, testing | Leave a Comment »
Larry Axmaker is an 8-year prostate cancer survivor and very happy he had regular PSA screenings!
Filed under: Diagnosis, Risk | Tagged: recommendation, screening, testing, USPSTF | 1 Comment »
This week’s issue issue of the New England Journal of Medicine includes four perspective articles on the recent draft recommendation about PSA screening issued by the U.S. Preventive Services Task Force (USPSTF).
Filed under: Diagnosis, Risk | Tagged: PSA, recommendation, screening, testing, USPSTF | 5 Comments »
The following editorial commentary related to the USPSTF recommendation was published on Friday, October 13, 2011 on the UroToday web site and is reproduced here with the permission of UroToday. The commentary was written by Alan Wein, MD,
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: PSA, recommendation, risk, screening, testing, USPSTF | 6 Comments »
The media – over the past few days — has taken every opportunity to “stoke the furore” about the USPSTF’s recommendation that PSA screening (of all men aged 50 to 75 years of age, or thereabouts) is not justified by the available data.
Filed under: Diagnosis, Management, Risk | Tagged: PSA, risk, testing, USPSTF | 3 Comments »
The “New” Prostate Cancer InfoLink has replicated below, in its entirety, a media release issued early this morning by the Prostate Cancer Foundation. We believe that this is precisely the correct response to the new USPSTF recommendation: acknowledgement of the realities of the USPSTF’s factually accurate recommendation and the recognition by the USPSTF that PSA [...]
Filed under: Diagnosis, Management, Risk | Tagged: PCF, Prostate cancer Foundation, screening, testing, USPSTF | 5 Comments »
There is a critically important portion of the USPSTF recommendation that few people seem to be noticing or acknowledging. It reads as follows:
Filed under: Diagnosis, Management, Risk | Tagged: risk, screening, testing | 3 Comments »
The U.S. Preventive Services Task Force (USPSTF) — after previously stating that it would be releasing its new recommendations about PSA testing for risk of prostate cancer on Tuesday next week — has been pressured (by a variety of organizations, and by the media) to release its draft recommendation today.
Filed under: Diagnosis, Risk | Tagged: Diagnosis, PSA, risk, testing, USPSTF | 14 Comments »
Back in 2006 a report from a research team in the Tyrol, Austria, suggested that the availability of free PSA testing for prostate cancer risk had lowered the risk of prostate cancer mortality in the Tyrol as compared to all other areas of Austria. This original study is discussed elsewhere on this web site.
Filed under: Diagnosis, Management, Risk | Tagged: mortality, PSA, screening, testing, Tyrol | 5 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site